Cigna Group (NYSE:CI) Upgraded to “Buy” at Wall Street Zen

Wall Street Zen upgraded shares of Cigna Group (NYSE:CI) from a hold rating to a buy rating in a research report report published on Saturday morning.

Several other research firms have also recently weighed in on CI. Deutsche Bank Aktiengesellschaft set a $415.00 price objective on Cigna Group and gave the company a “buy” rating in a report on Tuesday, August 5th. Robert W. Baird set a $372.00 target price on Cigna Group in a research note on Thursday, August 14th. TD Cowen upgraded Cigna Group to a “strong-buy” rating in a research note on Monday, June 23rd. Guggenheim restated a “buy” rating and issued a $350.00 target price (down previously from $388.00) on shares of Cigna Group in a research note on Monday, August 4th. Finally, Truist Financial set a $375.00 target price on Cigna Group in a research note on Tuesday, September 2nd. Two investment analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Cigna Group currently has a consensus rating of “Buy” and an average price target of $374.76.

Cigna Group Price Performance

Cigna Group stock opened at $302.71 on Friday. The firm has a market capitalization of $80.80 billion, a P/E ratio of 16.52, a PEG ratio of 0.90 and a beta of 0.48. Cigna Group has a 1 year low of $256.89 and a 1 year high of $370.83. The business has a 50-day moving average of $295.47 and a 200-day moving average of $312.04. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65.

Cigna Group (NYSE:CI) last released its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 earnings per share for the quarter, beating the consensus estimate of $7.15 by $0.05. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The business had revenue of $67.13 billion for the quarter, compared to analysts’ expectations of $62.61 billion. During the same quarter in the previous year, the business posted $6.72 EPS. Cigna Group’s revenue for the quarter was up 11.0% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, equities analysts anticipate that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 18th. Stockholders of record on Thursday, September 4th will be paid a dividend of $1.51 per share. The ex-dividend date is Thursday, September 4th. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.0%. Cigna Group’s dividend payout ratio is currently 32.97%.

Insider Activity

In other news, insider Nicole S. Jones sold 28,526 shares of the company’s stock in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the sale, the insider owned 25,648 shares in the company, valued at $7,694,400. This represents a 52.66% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. 0.70% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Cigna Group

A number of institutional investors and hedge funds have recently made changes to their positions in CI. Valeo Financial Advisors LLC raised its stake in shares of Cigna Group by 86,071.1% during the 2nd quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock worth $1,148,859,000 after purchasing an additional 3,471,249 shares in the last quarter. Norges Bank acquired a new position in shares of Cigna Group during the 2nd quarter worth approximately $1,110,426,000. Nuveen LLC acquired a new position in shares of Cigna Group during the 1st quarter worth approximately $727,905,000. GAMMA Investing LLC increased its holdings in shares of Cigna Group by 58,799.0% during the 1st quarter. GAMMA Investing LLC now owns 1,774,626 shares of the health services provider’s stock worth $583,852,000 after acquiring an additional 1,771,613 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD increased its holdings in shares of Cigna Group by 10.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider’s stock worth $3,966,690,000 after acquiring an additional 1,094,327 shares during the last quarter. Institutional investors own 86.99% of the company’s stock.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.